Histrelin implant and Ibritumomab Intravenous
Determining the interaction of Histrelin implant and Ibritumomab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: histrelin
Brand name: Supprelin LA, Vantas, Supprelin
Synonyms: Histrelin (implant), Histrelin
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab, Ibritumomab Tiuxetan
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Histrelin implant-Ibritumomab Tiuxetan
- Histrelin implant-Ibrutinib
- Histrelin implant-Ibrutinib Capsules
- Histrelin implant-Ibrutinib Tablets
- Histrelin implant-Ibu
- Histrelin implant-IBU Tablets
- Ibritumomab Intravenous-Histrelin Implant (CPP)
- Ibritumomab Intravenous-Histrelin Implant (Prostate Cancer)
- Ibritumomab Intravenous-Histrelin Subcutaneous
- Ibritumomab Intravenous-Histuss PD
- Ibritumomab Intravenous-Hivid
- Ibritumomab Intravenous-Hizentra